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Abstract
Objectives: This systematic review evaluated the evidence for the effectiveness of
Photodynamic therapy (PDT) in treating oral fungal infections, as an alternative to
conventional antifungal medications.
Methods: Five randomized control trials (168 participants) comparing the treatment
of oral fungal infections using met with our inclusion criteria. Clinical and microbio-
logical improvement was assessed by random-effects meta-analysis. Methodological
quality assessment and heterogeneity were performed using peer-reviewed criteria.
PROSPERO registration: CRD42017076.
Results: PDT showed statistically non-significant increased clinical efficacy (risk ratio
(RR) = 1.47 [95% confidence interval (CI), 0.68; 3.17]; three studies, n = 108 partici-
pants, I2 = 50%) and mycological efficacy (mean difference (MD) = 0.54 [95%CI,
−0.71; 1.79]; three studies, n = 100; I2 = 39%) at 30 days, as compared with conven-
tional antifungal therapy. Lack of standardization of treatment parameters and vari-
ability in the assessment of outcomes was observed across the studies. All included
studies had a moderate to low risk of bias.
Conclusions: PDT showed comparable effectiveness at treating oral fungal infections,
particularly denture stomatitis. The small number of studies in this review, small sam-
ple size and variability of methods and outcome measures across studies, highlight
the need for more standardized studies with longer follow-up periods to enable rec-
ommendation of PDT as an alternative to conventional antifungal therapy.
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1 | INTRODUCTION
Human fungal infections are a growing public health concern, affect-
ing more than 300 million people annually (Faini et al., 2015). Some of
the most common fungal infections in humans affect the oral cavity
and are seen in the critically ill, immune-compromised in neonates,
babies, and denture-wearers (Armstrong-James et al., 2014). They sig-
nificantly impact the oral health-related quality of life of the individual
due to oral discomfort, burning, pain, dysgeusia (altered taste) and
reduced appetite (Muzyka & Epifanio, 2013).
Treatment of oral fungal infections involves addressing
predisposing factors (local and systemic) and pharmacotherapy. Topi-
cal antifungals are the first line of treatment for mucocutaneous fun-
gal infections, followed by systemic antifungal medication (Muzyka &
Epifanio, 2013). However, fungi are rapidly gaining resistance to cur-
rently available medication (Denning & Bromley, 2015; dos Santos
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Abrantes et al., 2014; Pfaller, 2012). In a recent study, 50% of Candida
albicans specimens sampled were resistant to azoles (dos Santos
Abrantes et al., 2014) and new drugs to treat fungal infections have
not been developed since 2006 (Denning & Bromley, 2015). Alterna-
tive therapies are thus required to treat these minimally invasive fun-
gal infections without propagating the rise in fungal antimicrobial
resistance (Liang et al., 2016). Recently, the use of photodynamic ther-
apy (PDT) has garnered attention as a potential antifungal treatment
modality.
PDT, also referred to as photodynamic antimicrobial chemother-
apy (PACT), photoradiation therapy and photochemotherapy, com-
prises three components: a chemical photosensitizer (PS), the
application of light and the presence of oxygen. Briefly, the PS is
applied to the target tissue (either topically or systemically). Light of
an appropriate wavelength is then used to activate the PS, generating
highly reactive oxygen species (ROS), including the singlet oxygen, in
the target tissue. This results in cytotoxicity of the target cells and
elicits an acute inflammatory response in the surrounding tissues
(Konopka & Goslinski, 2007; Saini & Poh, 2013). Thus, PDT is being
studied as a treatment modality for a variety of clinical applications,
including the treatment of oral fungal infections; however, some
recent studies have found PDT to be inferior when compared with
antifungal medication in the treatment of specific oral fungal infec-
tions (Leite et al., 2015; Maciel et al., 2015). Given this equipoise, our
systematic review sought to review current evidence on the use of
PDT as a treatment modality for oral fungal infections in humans. In
addition, we sought to determine the most effective treatment regi-
men parameters, light delivery parameters and which type and con-
centration of photosensitizers are most effective for the treatment of
oral fungal infections. Lastly, we wished to determine how the risk
factors for oral fungal infections such as smoking and diabetes
mellitus, affect treatment outcomes.
2 | MATERIALS AND METHODS
The protocol of this review was registered with PROSPERO, registra-
tion number CRD42017076421 and strictly complied with the Pre-
ferred Reporting Items for Systematic Review and Meta-Analyses
(PRISMA) guidelines (Moher et al., 2009). This review received an
ethics waiver from the University of Cape Town, Faculty of Health
Science Human Research and Ethics Committee as this review relied
on only publicly available information (HREF 636/2018). No informed
consent was required for this review.
2.1 | Research question
This systematic review and meta-analysis were conducted to address
the following focused question: “Is photodynamic therapy compared
with standard anti-fungal treatment modalities, effective for the treat-
ment of oral fungal infections in humans?”
2.2 | Eligibility criteria
(a) Study design: Primary experimental and observational studies com-
paring the treatment of oral fungal infections using PDT to systemic
and topical antifungal treatment were included; (b) Participants:
Human participants with a clinical diagnosis and microbiological con-
firmation of an oral fungal infection; (c) Intervention: The use of PDT
to treat an oral fungal infection in vivo; (d) Comparator: Any study
using conventional topical or systemic antifungal medication for the
treatment of oral fungal infections. We allowed flexibility with the
antifungal drugs used and dosages of the comparator as treatment
regimens vary in different settings and for different patients;
(e) Outcome measures: The effectiveness of therapy was determined
via clinical assessment and microbiological confirmation via direct
microscopy or cell cultures. The presence or absence of Candida
hyphae can be assessed and a change from hyphae present to absent
would indicate improvement. Effectiveness was quantified by measur-
ing the change in fungal load. The latter was quantified as Candida col-
ony forming units per milliliter (CFU/mL). A decreased fungal load
indicated an improvement in the condition. Semi-quantification of
CFU/mL is interpreted similarly; (f) Time frame and language: No
restrictions.
2.3 | Search strategy
A comprehensive database search was initially conducted in
September 2018 using the following databases: The Cochrane Library,
BioMed, SciELO, Scopus, EBSCOhost, PubMed/MEDLINE, ISI Web of
Science, Clinicaltrials.gov, ProQuest, and WorldCat. The search strat-
egy has been detailed elsewhere (Table S1; Roomaney et al., 2020).
The results of the search were documented, reported and compared
between databases (Table S2; Roomaney et al., 2020). The references
were managed with EndNote (EndNote X9, version 9.2, Clarivate Ana-
lytics, USA) reference manager. An update on the search was con-
ducted in PubMed on June 30, 2020.
2.4 | Quality assessment
Each reviewer conducted an assessment of study quality and the risk
of bias of each included study using the risk of bias tools of the
Cochrane Collaboration (Higgins & Green, 2011).
2.5 | Study selection and data extraction
The search results were collated within an online document and two
researchers independently performed title and abstract screening,
followed by full-text evaluation and data extraction onto a pre-design
form. There was no disagreement between the reviewers on the stud-
ies to include.
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2.6 | Statistical analysis
Quantitative data was assessed using Review Manager (RevMan ver-
sion 5.3) statistical software and the data were pooled, where appro-
priate, to conduct a meta-analysis. Pooling of the data was done to
assess three outcomes: (1) clinical improvement from baseline,
(2) microbiological improvement by assessing changes in Candida col-
ony forming units per milliliter (CFU/ml), and (3) microbiological
improvement via semi-quantification of CFU's. The studies assessed
clinical change and microbiological change at different time points.
Forest plots were created for the time points of 7, 15 and 30 days
respectively. In conducting the meta-analysis, we used the number of
participants randomized to each arm, irrespective of withdrawal due
to incompletion of treatment or loss to follow-up, that is, intention-
to-treat analyses.
The effect size was estimated and reported from continuous vari-
ables using mean difference and 95% confidence intervals. The
weighting of each study was calculated using the inverse of the vari-
ance. A random-effects model was used for analysis (Borenstein
et al., 2010). Where the researchers found insufficient data, they con-
ducted a narrative report of the results.
The authors used the Cochrane test (P < 0.1 cut-off for statistical
significance) to determine statistical homogeneity and the I2 test was
used to quantify heterogeneity. The I2 test are interpreted as follows:
0%–40% may not be important; 30%–60% considered moderate het-
erogeneity; 50%–90% considered substantial heterogeneity; and
75%–100% is considerable heterogeneity (Higgins et al., 2019). Sub-
group analyses were planned to assess the following: the effect of dif-
ferent treatment parameters, including a comparison of different light
delivery devices, wavelengths, photosensitizers and different treat-
ment regimens i.e. duration of application, frequency of applications
and time between applications; the various antifungal medications
used; the effect of PDT on different fungal strains; and the effect of
comorbidities/predisposing medical conditions such as HIV, diabetes
mellitus, and dental prosthesis use. Publication bias was assessed via
funnel plots, however, the low number of studies rendered them
uninformative.
3 | RESULTS
3.1 | Literature search and study selection
The initial search yielded 654 titles (Figure 1). Two additional articles
were found by hand-searching reference lists of relevant articles.
Titles were collated and duplicates were excluded. The remaining
353 titles were evaluated, and 273 studies were excluded based on
titles. Subsequent abstract screening resulted in a further 68 being
excluded. We were unable to find the full-text for one article
(Cadastro & Giovani, 2009) leaving nine English language articles and
two Portuguese language articles subjected to full-text screening
(Abduljabbar et al., 2017; Alves et al., 2018; Barcessat et al., 2017;
Cadastro & Giovani, 2009; Maciel et al., 2016; Mima et al., 2011;
Ribeiro et al., 2012; Simunovic-Soskic et al., 2010). A further seven
articles were excluded for not fulfilling the inclusion criteria. Details
pertaining to the exclusion criteria are provided in the Supporting
Information (Table S3; Roomaney et al., 2020). An updated search
was conducted in June 2020 leading to the inclusion of an additional
study (Alrabiah et al., 2019). Five full-text studies were included in the
review.
3.2 | Characteristics of the included studies
The general characteristics of the included studies are presented in
Table 1. Four of the randomized control trials included were con-
ducted in Brazil (de Senna et al., 2018; Lopes, 2011; Mima
et al., 2012; Scwingel et al., 2012) and one was conducted in Saudi
Arabia (Alrabiah et al., 2019; N = 168). These studies comprise
between 14 and 54 enrolled participants each.
The description of parameters investigated, and technical char-
acteristics of the PDT used in the included studies are documented
in Table 2. Three studies conducted PDT on both dentures and oral
mucosa (Alrabiah et al., 2019; de Senna et al., 2018; Mima
et al., 2012). One study evaluated the treatment of oral candidiasis
in HIV positive patients (Scwingel et al., 2012), while the other four
studies specifically evaluated the treatment of denture stomatitis
(Alrabiah et al., 2019; de Senna et al., 2018; Lopes, 2011; Mima
et al., 2012).
Four studies used lasers as the light source (660 nm wave-
length). Twin lasers were used in two studies (Lopes, 2011;
Senna, 2012) and a GaAIA (Gallium aluminum arsenide) laser was
used in two studies (Alrabiah et al., 2019; Scwingel et al., 2012). The
studies investigating lasers utilized methylene blue as the PS. A sin-
gle study used a hematoporphyrin derivative as a PS, which was acti-
vated by an LED light of 440–460 nm wavelength (Mima
et al., 2012). The power of the LED used was 260 mW, which is sig-
nificantly higher than that provided by the lasers (100, 40, and
30 mW respectively). Pre-irradiation time, which is the length of
time between application of the PS and photoactivation, ranged
from 1 to 20 min. The length application of the laser per point was
between 10 s and 2 min. The length of application of the LED was
20 min. Treatment sessions varied from one session (Scwingel
et al., 2012) to two sessions 1 week apart (Lopes, 2011); to six ses-
sions over 15 days (Mima et al., 2012). The largest number of ses-
sions were eight PDT sessions over 4 weeks (Alrabiah et al., 2019;
de Senna et al., 2018).
Three studies used nystatin suspension as the comparator.
One advised rinsing with 5 mL of 100,000 IU suspension six times
a day for 2 weeks (Lopes, 2011) and the other two studies advised
rinsing with the same dosage, four times daily for 2 weeks
(Alrabiah et al., 2019; Mima et al., 2012). The study with HIV-
positive participants used 100 mg of fluconazole daily for 15 days
(Scwingel et al., 2012). In the fifth study, miconazole gel was
applied to the affected area three times daily for 4 weeks
(de Senna et al., 2018).
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3.3 | Method of clinical and microbiological
assessment
Four studies assessed clinical change using three methods. Two stud-
ies used the Budtz-Jørgensen et al. (1988) method before treatment
and 48 h after treatment (de Senna et al., 2018; Lopes, 2011). One
study (Mima et al., 2012) used Newton's classification (Newton, 1962)
and the other study used specified subjective comparisons from clini-
cal baseline to assess clinical changes (Scwingel et al., 2012). This was
done at baseline, end of treatment (day 15) and on follow-up (days
30, 60 and 90). Quantification of colony-forming units (CFUs) was
used to assess the microbiological success of treatment in three stud-
ies (Alrabiah et al., 2019; Lopes, 2011; Mima et al., 2012). The
remaining studies made use of semi-quantification of CFU/mL
(de Senna et al., 2018; Scwingel et al., 2012). This was either done via
visual assessment of the medium turbidity (clear, mild or intense) of
cell cultures in test tubes and then scored as low, medium or abundant
growth of fungus accordingly (Scwingel et al., 2012). Alternatively, the
CFUs were counted and expressed as degrees of density (de Senna
et al., 2018).
F IGURE 1 Schematic PRISMA flow diagram of the literature search. From: Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., The PRISMA
Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med, 6(7), e1000097.
doi:10.1371/journal.pmed1000097
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3.4 | Study outcomes
There was no statistically significant difference in clinical effective-
ness, that is, a reduction of oral lesions, between PDT and conven-
tional antifungal therapy at 30 days (risk ratio (RR) = 1.47 [95%
confidence interval (CI), 0.68; 3.17]; three studies, n = 108 partici-
pants; Figure 2a). Data for mycological efficacy assessed using semi-
quantification of CFUs supported these clinical findings (RR = 1.47
[95%CI, 0.69; 3.14]; three studies, n = 92; Figure 2b). Data for myco-
logical efficacy assessed using CFUs showed no difference between
the effectiveness of conventional (mean difference (MD) = 0.54 [95%
CI, −0.71; 1.79]; three studies, n = 100; Figure 2c).
PDT showed similar mycological effectiveness compared to conven-
tional medication, assessed at 7 days from the start of treatment
(Figure 3a; RR = 1.14 ([95%CI 0.68; 1.91]; two studies; n = 38) and at
15 days using direct measurements (Figure 3b; MD = 0.36 [−2.58; 3.31];
two studies; n = 64) and indirect measurements (Figure 3c; RR = 1.58
[95%CI 0.95; 2.64], two studies; n = 38; Figure 3c). Extent of heteroge-
neity was low (I2 = 20% (p = 0.26)) at 15 days and moderate (I2 = 39%
(p = 0.20)) at 30 days, which implies there was merit in pooling the data.
3.5 | Risk of bias of included studies
Contact was made with authors to clarify the risk of bias of included
studies. All included studies were found to have a moderate to low
risk of bias (Table 3). Authors reported that due to the nature of the
interventions, blinding of participants and personnel was not possible,
however, all studies reported blinding of outcome assessors. Only one
study reported allocation concealment (Alrabiah et al., 2019).
4 | DISCUSSION
This systematic review and meta-analysis found that photodynamic
therapy (PDT) showed equivalent effectiveness in resolving oral fun-
gal infections, however, to enable the recommendation of
implementing PDT as an alternative management modality requires
more studies with standardized methods and longer follow-up
periods.
This is the first systematic review and meta-analysis performed
on PDT and oral fungal infections analyzing only human studies. A
concerted effort was undertaken to make the literature search thor-
ough and comprehensive, limiting restrictions as much as possible.
Authors were contacted to retrieve missing information. Despite find-
ing only five studies meeting with our inclusion criteria, we were able
to conduct a meta-analysis to present aggregate data of PDT against
conventional therapy.
Although the study designs of the included studies were similar,
the studies demonstrated significant variability in their methods. The
biggest challenges were the lack of standardization of treatment
parameters across studies and inconsistency in the assessment of out-
comes. Thus, in conducting the meta-analysis, PDT was used as an
umbrella term for any intervention (regardless of parameters) meeting
our inclusion criterion. Three studies used the quantification of
colony-forming units (CFUs; Alrabiah et al., 2019; Lopes, 2011; Mima
et al., 2012) as the outcome measure, as opposed to the semi-
quantification of CFU's used by the remaining two studies (de Senna
et al., 2018; Scwingel et al., 2012). We conducted the planned sub-
group analyses where data was available; however, the results were
uninformative due to the small sample sizes after pooling of data.
Although every effort has been made to reduce bias within our
TABLE 1 Characteristics of included studies
Study Design Population Sample size Mean age, male: Female
Follow
up
Lopes, 2011 Randomized control trial Patients presenting to the
Dental Faculty at the
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Mima
et al., 2012
















Patients being seen by a
customer Service
Specialist at the City of




















Overall: 56.4 years, 1:17
Intervention: 58.1 ± 6 years;
1:9










Not provided 60 days




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6 ROOMANEY ET AL.
methods, these limitations should be considered when interpreting
the results of this review.
Finding the most effective treatment parameters was a second-
ary objective as optimal treatment parameters of PDT has not yet
been established in the literature. Treatment parameters varied sig-
nificantly across the studies and may have influenced treatment
outcomes. Since the optimal parameters of PDT are not yet
established, these studies may be underestimating the effectiveness
of PDT. Conversely, Antifungal medication used in the studies were
used empirically, that is, the antimicrobial sensitivity of the fungi
was not accounted for. Evidence exists that different fungal strains
have variable sensitivity to the currently available antifungal medi-
cations (dos Santos Abrantes et al., 2014). Thus, this may skew data
in favor of the PDT as the most appropriate antifungal medication
and dosage may not have been used. Similarly, there is evidence
that different fungal strains also have variable sensitivity to PDT
(Dovigo et al., 2010). Alrabiah et al. (2019) and Mima et al. (2012)
compared fungal species before and after treatment and had similar
findings. C. albicans was similarly sensitive to PDT and nystatin
(75% and 90% reduction), whereas, C. tropicalis appeared to be sig-
nificantly more sensitive to nystatin than PDT at 15 days (45% and
50% reduction). A laboratory study by Dovigo et al. (2010) compar-
ing the sensitivity of four fungal species to various PDT parameters
found that C. tropicalis required PDT at a greater energy density for
inactivation than that required by C. albicans. More research is
required to confirm the clinical implication of the variable sensitivi-
ties of different fungal species to PDT and this should be consid-
ered when designing future studies. Furthermore, four of the
studies focused on denture stomatitis. Other forms of oral fungal
infections are not adequately represented. Future studies should
focus on isolating fungal species, determining antimicrobial sensitiv-
ity and broadening the array of diseases being treated.
The few studies in our review precluded an assessment of the
effect of local risk factors (such as smoking, nocturnal denture
wearing, denture hygiene) and systemic risk factors such as HIV,
Diabetes mellitus and immunosuppressive therapies, on oral fungal
infection treatment outcomes. Smoking is a risk factor for oral fun-
gal infections and treatment outcomes tend to be inferior in
smokers compared to non-smokers (Abduljabbar et al., 2017). The
study by de Senna et al. (2018) which included four smokers found
that miconazole was more effective at reducing fungal load than
PDT. There was, however, only one smoker in the miconazole con-
trol group compared to three in the PDT group. Although the statis-
tical significance of this finding was not mentioned, it is important
to note that all smokers in the study presented with higher fungal
loads at follow-up. One study compared fluconazole treatment and
PDT in HIV-positive patients (Scwingel et al., 2012) but there was
no comparison between the response between HIV-positive and
immunocompetent individuals to determine if their response was
different. The remainder of the studies excluded patients with sys-
temic risk factors which limits the evidence for the use on PDT in
patients with systemic conditions and it is well established that
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F IGURE 2 Forest plot of (a) clinical efficacy, (b) mycological efficacy using semi-quantification of CFUs at 30 days, and (c) mycological
efficacy using quantification of CFUs
F IGURE 3 Forest plots of mycological effectiveness of treatment. (a) 7 Days using semi-quantification of CFUs, (b) 15 days using
quantification of CFUs, and (c) 15 days using semi-quantification of CFUs
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oral fungal infections. Therefore, it would be beneficial to include
patients with systemic and local risk factors and report on their
outcomes.
Recurrence of fungal infection has been mentioned as a particular
concern when using PDT (Lopes, 2011; Mima et al., 2012). This corre-
sponds to a recent case series treating five patients with denture sto-
matitis (Alves et al., 2018) which found recurrence in all patients at
the end of day 45 of follow-up. More studies beyond 30 days will be
required to assess if recurrence is a problem with PDT therapy in gen-
eral or to determine if it is related to the specific treatment parame-
ters used. If recurrence is found to be a problem with the use of PDT,
it would be important to assess whether new fungal species have
emerged, PDT-resistant species have developed or whether an insuffi-
cient reduction of patient risk factors is a possible contributory factor
to the recurrence.
The importance of finding alternatives to conventional antimicrobial
medication cannot be stressed enough. PDT appears to have potential as
a therapy for oral fungal infections. However, the lack of recent human
studies begs to question as to why progress into this area has stalled. At
present, it is still a relatively costly procedure requiring specialized equip-
ment, not commonly available in general dental offices. However, there
is an effort to create a more cost-effective LED light source (Daly
et al., 2017; Hempstead et al., 2015) which would make PDT more
accessible and provide greater scope to evaluate its impact than is cur-
rently possible. Moreover, other than recurrence, no major adverse
effects such as burning and pain, have been found with the use of PDT
in the treatment of oral fungal infections in this review. There is no risk
of drug interactions which is a considerable problem with some antifun-
gal medications. While little risk related to the use of PDT has been
reported, more clinical research is required on all aspects of PDT treat-
ment parameters. There is a need for well-designed clinical trials which
use standardized and objective clinical and microbiological outcome mea-
sures and comparable treatment parameters to allow a more robust
meta-analysis to be conducted and clinical guidelines to be developed.
The findings of this review and meta-analysis suggest that Photo-
dynamic therapy (PDT) is as effective at treating oral fungal infections,
particularly denture stomatitis, compared with conventional antifungal
medications, however, too little is known about the treatment param-
eters to endorse its clinical use. These findings are limited by the small
number of studies and sample sizes. This work emphasizes the impor-
tance of standardized methods in conducting trials of this nature,
ensuring high-quality research with low risk of bias, adequate sample
sizes and longer follow-up periods with adequate reporting of other
risk factors, given that they may affect treatment outcomes.
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